Healthcare & Medical Devices Global On demand · 24-48h

Global Medical Absorbable Interference Screws Market Strategic Research Report

Global Medical Absorbable Interference Screws Market Strateg…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Medical Absorbable Interference Screws Market
$2392025
7%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Polymer, Biocomposite

By Application: Hospitals, Ambulatory Surgery Centers, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Arthrex, Smith & Nephew, Stryker, Johnson & Johnson, CONMED, Medacta International, Biocomposites, Richard Wolf, FH Ortho, Teknimed, Biomatlante, S.B.M. France, Inion, Bioretec, Weigao Group, Naton, STAR Sports Medicine, SinoBiom, REJOIN, iKey Medical

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 138 pages
Market size 2025
$239
Million USD
Forecast CAGR
7%
2025-2032
Forecast 2032
$383.8
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

نظرة عامة

Scope of the Report

The global Medical Absorbable Interference Screws market size is predicted to grow from US$ 239 million in 2025 to US$ 383 million in 2032; it is expected to grow at a CAGR of 7.0% from 2026 to 2032.

Medical Absorbable Interference Screws are implantable fixation devices used in orthopedic sports medicine procedures. They are mainly inserted into bone tunnels during arthroscopic ligament or tendon reconstruction, where the threaded structure provides compression and interface fixation to secure the graft within the bone. These products are typically made of absorbable polymers or biocomposite materials, gradually degrade and are absorbed during the healing process, and some designs can support bone ingrowth and bone integration, thereby reducing long term foreign body retention and the need for later removal surgery. Medical Absorbable Interference Screws typically cost several hundred dollars each, with gross margins usually between 60% and 75%.

The upstream supply chain of Medical Absorbable Interference Screws mainly includes absorbable medical grade polymers, bioceramic fillers, precision molds, sterile packaging materials, sterilization services and implant grade quality testing services, where material purity, mechanical stability and degradation consistency directly affect product performance. The midstream consists of sports medicine implant manufacturers and orthopedic device companies, with key processes covering product design, material formulation, precision molding, size series development, sterilization packaging, regulatory registration and clinical promotion. Downstream customers mainly include orthopedic departments of general hospitals, sports medicine centers, arthroscopic surgery centers, specialty hospitals and distributor channels, while end market demand is closely related to sports injury treatment, ligament reconstruction procedure volume, surgeon preference, reimbursement conditions and hospital procurement policies.

The Medical Absorbable Interference Screws market is a specialized segment of high value orthopedic sports medicine consumables, mainly driven by anterior cruciate ligament, posterior cruciate ligament and other ligament or tendon reconstruction procedures. With the wider adoption of minimally invasive arthroscopic surgery, rising treatment volume for sports injuries and increasing demand for imaging compatibility and reduced risk of secondary removal, absorbable interference screws have become an important option for ligament fixation. Competition in this market is shifting from basic fixation strength toward material biocompatibility, controllable degradation, bone integration, comprehensive size offering and surgical convenience, while companies with broad sports medicine portfolios, clinical education capabilities and strong channel coverage are better positioned to build competitive advantages.

This report presents a comprehensive overview of the global Medical Absorbable Interference Screws market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Polymer
  • Biocomposite

Segment by Length

  • <20 mm
  • 20 mm-30 mm
  • >30 mm

Segment by Thread Coverage

  • Fully Threaded
  • Partially Threaded

Segment by Application

  • Hospitals
  • Ambulatory Surgery Centers
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Medical Absorbable Interference Screws market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospitals, Ambulatory Surgery Centers, Others evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Medical Absorbable Interference Screws Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 7%
Regional growth momentum
Market share by segment
Key metrics
Base value
$239
2025
Forecast
$383.8
2032
CAGR
7%
2025–2032
Regions
5
global
Key companies
ArthrexSmith & NephewStrykerJohnson & JohnsonCONMEDMedacta InternationalBiocompositesRichard Wolf
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
PolymerBiocomposite
By Application
HospitalsAmbulatory Surgery CentersOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Polymer
  • 3.1.3 Biocomposite
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospitals
  • 4.1.3 Ambulatory Surgery Centers
  • 4.1.4 Others
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Arthrex
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Smith & Nephew
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Stryker
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Johnson & Johnson
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 CONMED
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Medacta International
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Biocomposites
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Richard Wolf
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 FH Ortho
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Teknimed
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Biomatlante
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 S.B.M. France
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Inion
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Bioretec
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Weigao Group
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Naton
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 STAR Sports Medicine
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 SinoBiom
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 REJOIN
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 iKey Medical
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Medical Absorbable Interference Screws market?
The global Medical Absorbable Interference Screws market is estimated at US$ 239 million in 2025 (base year) and is projected to reach US$ 383 million by 2032.
How fast is the Medical Absorbable Interference Screws market expected to grow?
The market is expected to grow at a CAGR of 7.0% from 2026 to 2032, expanding from US$ 239 million in 2025 to US$ 383 million in 2032, roughly 1.6 times its base-year value.
What does the Medical Absorbable Interference Screws market cover?
Medical Absorbable Interference Screws are implantable fixation devices used in orthopedic sports medicine procedures. They are mainly inserted into bone tunnels during arthroscopic ligament or tendon reconstruction, where the threaded structure provides compression and interface fixation to secure the graft within the bone.
What are the main segments of the Medical Absorbable Interference Screws market by type?
By type, the market is segmented into Polymer and Biocomposite.
Which applications drive demand in the Medical Absorbable Interference Screws market?
Key applications covered include Hospitals, Ambulatory Surgery Centers and Others.
Who are the key players in the Medical Absorbable Interference Screws market?
Key players profiled include Arthrex, Smith & Nephew, Stryker, Johnson & Johnson, CONMED, Medacta International, Biocomposites and Richard Wolf, among 20 companies covered in total.
Which regions and countries are covered for Medical Absorbable Interference Screws?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Medical Absorbable Interference Screws market?
The Medical Absorbable Interference Screws market is a specialized segment of high value orthopedic sports medicine consumables, mainly driven by anterior cruciate ligament, posterior cruciate ligament and other ligament or tendon reconstruction procedures.
Who should buy the Medical Absorbable Interference Screws market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospitals, Ambulatory Surgery Centers and Others, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Medical Absorbable Interference Screws market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from ‏3,500.00 US$
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.